ClinicalTrials.govpublic full text
Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan
diabetes mellitus, type 2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 463694
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.